991 articles by Susan Kelly
-
Diagnostic errors are common. Here are 4 ways to prevent them.
Sept. 6, 2024 -
Edwards cuts more than 500 employees after critical care sale
Sept. 5, 2024 -
Illumina avoids fine for Grail purchase in European court victory
Sept. 3, 2024 -
Pathology group sues to block FDA lab test rule
Aug. 30, 2024 -
Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care
Aug. 27, 2024 -
Stryker to add back pain treatment with Vertos Medical buy
Aug. 23, 2024 -
FDA defends Shuren’s tenure after report raises ethics concerns
Aug. 22, 2024 -
Masimo’s consumer audio brands attract more suitors
Aug. 21, 2024 -
J&J to buy heart failure implant maker V-Wave for up to $1.7B
Aug. 20, 2024 -
Edwards continues M&A spree with Genesis’ TAVR tech
Aug. 19, 2024 -
Histosonics raises $102M for noninvasive treatment to destroy tumors
Aug. 19, 2024 -
Stereotaxis earns CE mark for new surgical robot
Aug. 15, 2024 -
Grail to shed 350 workers in restructuring
Aug. 14, 2024 -
Baxter agrees to sell kidney care unit to Carlyle for $3.8B
Aug. 13, 2024 -
Experts fear patient harm from FDA’s lab developed test rule
Aug. 5, 2024 -
GE Healthcare faces pressure in China as hospitals delay orders
Aug. 1, 2024 -
Guardant wins FDA approval for colon cancer blood test
July 29, 2024 -
Edwards spends $1.2B on 2 heart device firms, extending deal streak
July 25, 2024 -
CDRH Director Shuren to step down after 15 years
July 24, 2024 -
ICU Medical to close Minnesota facility, cut 83 jobs
July 23, 2024 -
‘Our next frontier is prediction’: Medtronic on AI and heart disease
July 22, 2024 -
Intuitive’s da Vinci 5 robot launch ‘well ahead’ of Wall Street expectations
July 19, 2024 -
Masimo sues activist investor Politan, postpones annual meeting
July 16, 2024 -
Edwards to acquire Innovalve, stake in Affluent Medical
July 15, 2024 -
FDA’s lab developed test rule could be first check on agency’s power post-Chevron
July 11, 2024